Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2025

Abstract
Apex Market Research has published a new report titled ”Global Blood Screening Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global Blood Screening market is estimated to grow from USD 1.9 billion in 2020 to USD 3.5 billion by 2025, at a CAGR of 12.8%. The report offers in-depth insights, revenue details, and other vital information regarding the global Blood Screening market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Blood Screening market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Blood Screening market report offers in-depth insights, revenue details, and other vital information regarding the global Blood Screening market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Blood Screening market. The major players operating into Blood Screening Market include: Grifols (Spain)
F. Hoffmann-La Roche AG (Switzerland)
Abbott Laboratories (US)
BioMrieux (France)
Bio-Rad Laboratories (US)
Siemens Healthineers (Germany)
Danaher Corporation (US)
Thermo Fisher Scientific Inc. (US)
Ortho Clinical Diagnostics
Inc. (US)
Becton
Dickinson and Company (US)
DiaSorin (Italy)
GFE (Germany)
Trinity Biotech (Ireland)
Merck Millipore (Germany)
GE Healthcare (US)
Perkin Elmer (US)
Bio-Techne Corporation (US)
and J Mitra & Co. Pvt. Ltd (India). Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value Value (USD)
Covered Segments Product & service, technology, end user, and region
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Blood Screening market to forecast revenues and analyze trends in each of the following submarkets:

By Product & Service

  • Reagents and Kits
  • NAT Reagents and Kits
    • Enzymes and Polymerases
    • Standards and Controls
    • Probes and Primers
    • Buffers, Nucleotides, and Solutions
    • Labeling and Detection Reagents
  • ELISA Reagents and Kits
    • Immunosorbents
    • Controls
    • Conjugates
    • Substrates
    • Sample Diluents and Wash Solutions
  • Other Reagents and Kits
  • Instruments
  • Outright Purchase
  • Rental Purchase
  • Software and Services

By Technology

  • NAT
    • Transcription-Mediated Amplification
    • Real-time Polymerase Chain Reaction
  • ELISA
    • Chemiluminescent Immunoassay
    • Fluorescent immunoassay
    • Colorimetric Immunoassay
  • Rapid Tests
  • Western Blot Assays
  • NGS

By End User

  • Blood Banks
  • Hospitals
By geography, this market has been segregated into five regions with revenue and growth rate of Blood Screening from 2020 to 2027,
There are 13 chapters to put on view for Blood Screening Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Blood Screening Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Blood Screening Market Overview 1.1.1 Blood Screening Product Scope 1.1.2 Market Status and Outlook 1.2 Global Blood Screening Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Blood Screening Market Status and Outlook 1.2.2 EU Blood Screening Market Status and Outlook 1.2.3 Japan Blood Screening Market Status and Outlook 1.2.4 China Blood Screening Market Status and Outlook 1.2.5 India Blood Screening Market Status and Outlook 1.2.6 Southeast Asia Blood Screening Market Status and Outlook 1.3 Global Blood Screening Market Segment By Product & Service
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.1 Reagents and Kits
1.3.1.1 Market Estimates And Forecast By Country, 2015-2027
1.3.2 NAT Reagents and Kits
1.3.2.1 Enzymes and Polymerases
1.3.2.2 Standards and Controls
1.3.2.3 Probes and Primers
1.3.2.4 Buffers, Nucleotides, and Solutions
1.3.2.5 Labeling and Detection Reagents
1.3.2.6 Market Estimates And Forecast By Country, 2015-2027
1.3.3 ELISA Reagents and Kits
1.3.3.1 Immunosorbents
1.3.3.2 Controls
1.3.3.3 Conjugates
1.3.3.4 Substrates
1.3.3.5 Sample Diluents and Wash Solutions
1.3.3.6 Market Estimates And Forecast By Country, 2015-2027
1.3.3.5 Other Reagents and Kits
1.3.3.6 Market Estimates And Forecast By Country, 2015-2027
1.3.3.5 Instruments
1.3.3.6 Market Estimates And Forecast By Country, 2015-2027
1.3.3.5 Outright Purchase
1.3.3.6 Market Estimates And Forecast By Country, 2015-2027
1.3.3.5 Rental Purchase
1.3.3.6 Market Estimates And Forecast By Country, 2015-2027
1.3.3.5 Software and Services
1.3.3.6 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Blood Screening Market Segment By Technology
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.2 NAT
1.4.2.1 Transcription-Mediated Amplification
1.4.2.2 Real-time Polymerase Chain Reaction
1.4.2.3 Market Estimates And Forecast By Country, 2015-2027
1.4.3 ELISA
1.4.3.1 Chemiluminescent Immunoassay
1.4.3.2 Fluorescent immunoassay
1.4.3.3 Colorimetric Immunoassay
1.4.3.4 Market Estimates And Forecast By Country, 2015-2027
1.4.3.3 Rapid Tests
1.4.3.4 Market Estimates And Forecast By Country, 2015-2027
1.4.3.3 Western Blot Assays
1.4.3.4 Market Estimates And Forecast By Country, 2015-2027
1.4.3.3 NGS
1.4.3.4 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Blood Screening Competition Analysis by Players 2.1 Global Blood Screening Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Grifols (Spain) 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Grifols (Spain), Blood Screening Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 F. Hoffmann-La Roche AG (Switzerland) 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 F. Hoffmann-La Roche AG (Switzerland), Blood Screening Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Abbott Laboratories (US) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Abbott Laboratories (US), Blood Screening Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 BioMrieux (France) 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 BioMrieux (France), Blood Screening Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Bio-Rad Laboratories (US) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Bio-Rad Laboratories (US), Blood Screening Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 Siemens Healthineers (Germany) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Siemens Healthineers (Germany), Blood Screening Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Danaher Corporation (US) 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Danaher Corporation (US), Blood Screening Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Thermo Fisher Scientific Inc. (US) 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Thermo Fisher Scientific Inc. (US), Blood Screening Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Ortho Clinical Diagnostics 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Ortho Clinical Diagnostics, Blood Screening Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Inc. (US) 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Inc. (US), Blood Screening Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Blood Screening Market Size Type (2015-2019) 4.1 Global Blood Screening Market Size by Type (2015-2019) Chapter 5 Global Blood Screening Market Size Application (2015-2019) 5.1 Global Blood Screening Market Size by Application (2015-2019) 5.2 Potential Application of Blood Screening in Future 5.3 Top Consumer / End Users of Blood Screening Chapter 6 North America Blood Screening Development Status and Outlook 6.1 North America Blood Screening Market Size (2015-2019) 6.2 North America Blood Screening Market Size by Application (2015-2019) Chapter 7 EU Blood Screening Development Status and Outlook 7.1 EU Blood Screening Market Size (2015-2019) 7.2 EU Blood Screening Market Size by Application (2015-2019) Chapter 8 Japan Blood Screening Development Status and Outlook 8.1 Japan Blood Screening Market Size (2015-2019) 8.2 Japan Blood Screening Market Size by Application (2015-2019) Chapter 9 China Blood Screening Development Status and Outlook 9.1 China Blood Screening Market Size and Forecast (2015-2019) 9.2 China Blood Screening Market Size by Application (2015-2019) Chapter 10 India Blood Screening Development Status and Outlook 10.1 India Blood Screening Market Size and Forecast (2015-2019) 10.2 India Blood Screening Market Size by Application (2015-2019) Chapter 11 Southeast Asia Blood Screening Development Status and Outlook 11.1 Southeast Asia Blood Screening Market Size and Forecast (2015-2019) 11.2 Southeast Asia Blood Screening Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Blood Screening Market Size (Million USD) by Regions (2020-2027) 12.1. North America Blood Screening Revenue and Growth Rate (2020-2027) 12.1.2 EU Blood Screening Revenue and Growth Rate (2020-2027) 12.1.3 China Blood Screening Revenue and Growth Rate (2020-2027) 12.1.4 Japan Blood Screening Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Blood Screening Revenue and Growth Rate (2020-2027) 12.1.6 India Blood Screening Revenue and Growth Rate (2020-2027) 12.2 Global Blood Screening Market Size by Application (2020-2027) Chapter 13 Blood Screening Market Dynamics 13.1 Blood Screening Market Opportunities 13.2 Blood Screening Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Blood Screening Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Blood Screening Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1453

2677

OUR CLIENT